The Medical Research Council (MRC) has launched a new £5m call for capital investment to support between two and five human tissue banks with linked data resources. Awards will be made to teams of academics working in close partnership with medical research charities.
What maintains stroke survivors’ continued use of self-managed computer therapy for aphasia?
‘Supported self-management’ is the help and support offered to stroke survivors and their families after they have left hospital. This research will look at what does and doesn’t work to help stroke survivors and their families to self-manage.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after brain haemorrhage.
Junior Research Training Fellowship: Christine Hazelton
Video interview highlights from ten key trials that presented at ESOC 2016.
Using genetics to understand why disease of the small blood vessels in the brain occurs.
CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
This project will develop a special therapy area within ‘Second Life’, an existing virtual reality world on the internet. It will be protected so that only other people with aphasia and specially trained support workers can take part.
Cerebral small vessel disease (SVD) is usually associated with high blood pressure, and causes 20% of all strokes. It is the main cause of cognitive changes and dementia associated with stroke. Behavioural symptoms such as apathy are also common in patients with SVD.